A.T. Coste

Discipline

Sciences de l'information et de la communication (1) Economies et finances (1)

Type de document

Articles (23) Recensions (7)

Co-auteur

Date

Source

Mot-clé

Treatment (13) Patients (11) Patients (11) résistance (11) Testing (10) Testing (10) infection (9) Infection (9) agent pathogène (8) Human beings (8) Candida albicans (8) Susceptibility (8) temps (durée) (7) thérapie (7) espèce (7) analyse (7) Genes (7) Time (7) Therapeutics (7) Species (7) Example (7) Candida (7) Analysis (7) modèle (5) méthode (5) Methods (5) Identification (5) Yeast (5) Mycoses (5) Identification (5)

Documents écrit par A.T. Coste (23) | parle de A.T. Coste (0)

Échinococcose alvéolaire : prise en charge en 2023 [2023 update on alveolar echinococcosis]
E. Gauthiez et al. (12 avr. 2023)
How Yeast Antifungal Resistance Gene Analysis Is Essential to Validate Antifungal Susceptibility Testing Systems.
N. Pellaton et al. (2022)
Assessment of the In Vitro and In Vivo Antifungal Activity of NSC319726 against Candida auris.
J. Li et al. (22 déc. 2021)
Performance evaluation of the Becton Dickinson Kiestra™ IdentifA/SusceptA.
D. Jacot et al.
Self-testing for SARS-CoV-2: importance of lay communication.
A.T. Coste et al. (24 mai 2021)
Emerging echinocandin-resistant Candida albicans and glabrata in Switzerland.
A.T. Coste et al.
Diagnostic strategies for SARS-CoV-2 infection and interpretation of microbiological results.
G. Caruana et al.
Conidiobolus pachyzygosporus invasive pulmonary infection in a patient with acute myeloid leukemia: case report and review of the literature.
E. Stavropoulou et al. (22 juil. 2020)
Evaluation of the BD Phoenix™ CPO Detect Test for the detection of carbapenemase producers.
A. Croxatto et al.
Ability of quantitative PCR to discriminate Pneumocystis jirovecii pneumonia from colonization.
T. Perret et al.
Condition-specific series of metabolic sub-networks and its application for gene set enrichment analysis.
VDT Tran et al. (1 juil. 2019)
Investigating Antifungal Susceptibility in Candida Species With MALDI-TOF MS-Based Assays.
M. Delavy et al. (2019)
Review on Antifungal Resistance Mechanisms in the Emerging Pathogen Candida auris.
F. Chaabane et al. (2019)
Machine Learning Approach for Candida albicans Fluconazole Resistance Detection Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry.
M. Delavy et al. (2019)
Review of the impact of MALDI-TOF MS in public health and hospital hygiene, 2018.
B. Rodríguez-Sánchez et al.
Unexpected Transcripts in Tn7 orf19.2646 C. albicans Mutant Lead to Low Fungal Burden Phenotype In vivo.
A. Pierrehumbert et al. (2017)
Azole Resistance in Aspergillus fumigatus: A Consequence of Antifungal Use in Agriculture?
S. Berger et al. (2017)
Red-Shifted Firefly Luciferase Optimized for Candida albicans In vivo Bioluminescence Imaging.
S. Dorsaz et al. (2017)
Pleiotropic effects of the vacuolar ABC transporter MLT1 of Candida albicans on cell function and virulence.
N.K. Khandelwal et al. (1 juin 2016)
Examining the virulence of Candida albicans transcription factor mutants using Galleria mellonella and mouse infection models.
S. Amorim-Vaz et al. (2015)
Antifungal resistance and new strategies to control fungal infections.
P. Vandeputte et al. (2012)
In Vivo Systematic Analysis of Candida albicans Zn2-Cys6 Transcription Factors Mutants for Mice Organ Colonization.
P. Vandeputte et al. (2011)
Doxorubicin induces drug efflux pumps in Candida albicans.
G. Kofla et al. (2011)